Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1988 Oct;58(4):502–504. doi: 10.1038/bjc.1988.250

Peritoneal trauma releases CA125?

C W Redman 1, S R Jones 1, D M Luesley 1, S E Nicholl 1, K Kelly 1, E J Buxton 1, K K Chan 1, G R Blackledge 1
PMCID: PMC2246796  PMID: 3207605

Full text

PDF
502

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atack D. B., Nisker J. A., Allen H. H., Tustanoff E. R., Levin L. CA 125 surveillance and second-look laparotomy in ovarian carcinoma. Am J Obstet Gynecol. 1986 Feb;154(2):287–289. doi: 10.1016/0002-9378(86)90657-5. [DOI] [PubMed] [Google Scholar]
  2. Barbieri R. L., Niloff J. M., Bast R. C., Jr, Scaetzl E., Kistner R. W., Knapp R. C. Elevated serum concentrations of CA-125 in patients with advanced endometriosis. Fertil Steril. 1986 May;45(5):630–634. doi: 10.1016/s0015-0282(16)49333-7. [DOI] [PubMed] [Google Scholar]
  3. Bast R. C., Jr, Klug T. L., St John E., Jenison E., Niloff J. M., Lazarus H., Berkowitz R. S., Leavitt T., Griffiths C. T., Parker L. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med. 1983 Oct 13;309(15):883–887. doi: 10.1056/NEJM198310133091503. [DOI] [PubMed] [Google Scholar]
  4. Bergmann J. F., Bidart J. M., George M., Beaugrand M., Levy V. G., Bohuon C. Elevation of CA 125 in patients with benign and malignant ascites. Cancer. 1987 Jan 15;59(2):213–217. doi: 10.1002/1097-0142(19870115)59:2<213::aid-cncr2820590206>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  5. Cruickshank D. J., Fullerton W. T., Klopper A. The clinical significance of pre-operative serum CA 125 in ovarian cancer. Br J Obstet Gynaecol. 1987 Jul;94(7):692–695. doi: 10.1111/j.1471-0528.1987.tb03177.x. [DOI] [PubMed] [Google Scholar]
  6. Duk J. M., Aalders J. G., Fleuren G. J., de Bruijn H. W. CA 125: a useful marker in endometrial carcinoma. Am J Obstet Gynecol. 1986 Nov;155(5):1097–1102. doi: 10.1016/0002-9378(86)90358-3. [DOI] [PubMed] [Google Scholar]
  7. Halila H., Stenman U. H., Seppälä M. Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancy. Cancer. 1986 Apr 1;57(7):1327–1329. doi: 10.1002/1097-0142(19860401)57:7<1327::aid-cncr2820570713>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  8. Kabawat S. E., Bast R. C., Welch W. R., Knapp R. C., Colvin R. B. Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types. Am J Clin Pathol. 1983 Jan;79(1):98–104. doi: 10.1093/ajcp/79.1.98. [DOI] [PubMed] [Google Scholar]
  9. Krebs H. B., Goplerud D. R., Kilpatrick S. J., Myers M. B., Hunt A. Role of Ca 125 as tumor marker in ovarian carcinoma. Obstet Gynecol. 1986 Apr;67(4):473–477. [PubMed] [Google Scholar]
  10. Malkasian G. D., Jr, Podratz K. C., Stanhope C. R., Ritts R. E., Jr, Zurawski V. R., Jr CA 125 in gynecologic practice. Am J Obstet Gynecol. 1986 Sep;155(3):515–518. doi: 10.1016/0002-9378(86)90269-3. [DOI] [PubMed] [Google Scholar]
  11. Niloff J. M., Bast R. C., Jr, Schaetzl E. M., Knapp R. C. Predictive value of CA 125 antigen levels in second-look procedures for ovarian cancer. Am J Obstet Gynecol. 1985 Apr 1;151(7):981–986. doi: 10.1016/0002-9378(85)90678-7. [DOI] [PubMed] [Google Scholar]
  12. Schilthuis M. S., Aalders J. G., Bouma J., Kooi H., Fleuren G. J., Willemse P. H., De Bruijn H. W. Serum CA 125 levels in epithelial ovarian cancer: relation with findings at second-look operations and their role in the detection of tumour recurrence. Br J Obstet Gynaecol. 1987 Mar;94(3):202–207. doi: 10.1111/j.1471-0528.1987.tb02354.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES